Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-sp...

Full description

Bibliographic Details
Main Authors: Ruichao Zeng, Ahmed Mohamed, Kum Kum Khanna, Michelle M. Hill
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/13/3330
_version_ 1797528090053705728
author Ruichao Zeng
Ahmed Mohamed
Kum Kum Khanna
Michelle M. Hill
author_facet Ruichao Zeng
Ahmed Mohamed
Kum Kum Khanna
Michelle M. Hill
author_sort Ruichao Zeng
collection DOAJ
description Triple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-specific glycogenes and pathways, as well as their upstream regulatory mechanisms. Unsupervised clustering of 345 glycogene expressions in breast cancer datasets revealed a relative homogenous expression pattern in basal-like TNBC subtype. Differential expression analyses of the 345 glycogenes between basal-like TNBC (hereafter termed TNBC) and other BC subtypes, or normal controls, revealed 84 differential glycogenes in TNBC. Pathway enrichment showed two common TNBC-enriched pathways across all three datasets, cell cycle and lacto-/neolacto- glycosphingolipid (GSL) biosynthesis, while a total of four glycosylation-related pathways were significantly enriched in TNBC. We applied a selection criterion of the top 50% differential anabolic/catabolic glycogenes in the enriched pathways to define 34 TNBC-specific glycogenes. The lacto-/neolacto- GSL biosynthesis pathway was the most highly enriched, with seven glycogenes all up-regulated in TNBC. This data led us to investigate the hypothesis that a common upstream mechanism in TNBC up-regulates the lacto-/neolacto-GSL biosynthesis pathway. Using public multi-omic datasets, we excluded the involvement of copy-number alteration and DNA methylation, but identified three transcription factors (AR, GATA3 and ZNG622) that each target three candidate genes in the lacto-/neolacto- GSL biosynthesis pathway. Interestingly, a subset of TNBC has been reported to express AR and GATA3, and AR antagonists are being trialed for TNBC. Our findings suggest that AR and GATA3 may contribute to TNBC via GSL regulation, and provide a list of candidate glycogenes for further investigation.
first_indexed 2024-03-10T09:53:09Z
format Article
id doaj.art-bde1f029d7f24f5481561d25ff3619e4
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T09:53:09Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-bde1f029d7f24f5481561d25ff3619e42023-11-22T02:36:13ZengMDPI AGCancers2072-66942021-07-011313333010.3390/cancers13133330Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast CancerRuichao Zeng0Ahmed Mohamed1Kum Kum Khanna2Michelle M. Hill3Precision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaSignal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaPrecision & Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaTriple-negative breast cancer (TNBC) is an aggressive breast cancer with limited treatment options. Glycosylation has been implicated in cancer development, but TNBC-specific glycosylation pathways have not been examined. Here, we applied bioinformatic analyses on public datasets to discover TNBC-specific glycogenes and pathways, as well as their upstream regulatory mechanisms. Unsupervised clustering of 345 glycogene expressions in breast cancer datasets revealed a relative homogenous expression pattern in basal-like TNBC subtype. Differential expression analyses of the 345 glycogenes between basal-like TNBC (hereafter termed TNBC) and other BC subtypes, or normal controls, revealed 84 differential glycogenes in TNBC. Pathway enrichment showed two common TNBC-enriched pathways across all three datasets, cell cycle and lacto-/neolacto- glycosphingolipid (GSL) biosynthesis, while a total of four glycosylation-related pathways were significantly enriched in TNBC. We applied a selection criterion of the top 50% differential anabolic/catabolic glycogenes in the enriched pathways to define 34 TNBC-specific glycogenes. The lacto-/neolacto- GSL biosynthesis pathway was the most highly enriched, with seven glycogenes all up-regulated in TNBC. This data led us to investigate the hypothesis that a common upstream mechanism in TNBC up-regulates the lacto-/neolacto-GSL biosynthesis pathway. Using public multi-omic datasets, we excluded the involvement of copy-number alteration and DNA methylation, but identified three transcription factors (AR, GATA3 and ZNG622) that each target three candidate genes in the lacto-/neolacto- GSL biosynthesis pathway. Interestingly, a subset of TNBC has been reported to express AR and GATA3, and AR antagonists are being trialed for TNBC. Our findings suggest that AR and GATA3 may contribute to TNBC via GSL regulation, and provide a list of candidate glycogenes for further investigation.https://www.mdpi.com/2072-6694/13/13/3330triple-negative breast cancerglycosylationglycogenesglycosphingolipidslactoneo-lacto
spellingShingle Ruichao Zeng
Ahmed Mohamed
Kum Kum Khanna
Michelle M. Hill
Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
Cancers
triple-negative breast cancer
glycosylation
glycogenes
glycosphingolipids
lacto
neo-lacto
title Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
title_full Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
title_fullStr Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
title_full_unstemmed Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
title_short Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer
title_sort differential regulation of lacto neolacto glycosphingolipid biosynthesis pathway reveals transcription factors as potential candidates in triple negative breast cancer
topic triple-negative breast cancer
glycosylation
glycogenes
glycosphingolipids
lacto
neo-lacto
url https://www.mdpi.com/2072-6694/13/13/3330
work_keys_str_mv AT ruichaozeng differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer
AT ahmedmohamed differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer
AT kumkumkhanna differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer
AT michellemhill differentialregulationoflactoneolactoglycosphingolipidbiosynthesispathwayrevealstranscriptionfactorsaspotentialcandidatesintriplenegativebreastcancer